PACS Group, Inc. (NYSE:PACS – Get Free Report) insider Mark Hancock sold 153,254 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $36.34, for a total value of $5,569,250.36. Following the completion of the sale, the insider owned 54,449,343 shares of the company’s stock, valued at approximately $1,978,689,124.62. This trade represents a 0.28% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Hancock also recently made the following trade(s):
- On Tuesday, June 16th, Mark Hancock sold 83,066 shares of PACS Group stock. The shares were sold at an average price of $35.90, for a total value of $2,982,069.40.
PACS Group Stock Performance
PACS Group stock opened at $36.67 on Friday. The stock’s 50 day moving average price is $35.88 and its 200 day moving average price is $35.98. The firm has a market capitalization of $5.80 billion and a PE ratio of 23.51. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.99 and a current ratio of 0.99. PACS Group, Inc. has a one year low of $7.50 and a one year high of $43.08.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of PACS Group in a report on Friday, March 27th. Truist Financial boosted their price objective on shares of PACS Group from $50.00 to $52.00 and gave the stock a “buy” rating in a report on Monday, May 18th. Oppenheimer upped their price objective on shares of PACS Group from $42.00 to $48.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Zacks Research downgraded PACS Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, May 14th. Finally, UBS Group lifted their target price on PACS Group from $42.00 to $44.00 and gave the stock a “buy” rating in a research report on Wednesday, March 4th. Five investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $48.00.
Check Out Our Latest Report on PACS
Hedge Funds Weigh In On PACS Group
Several institutional investors and hedge funds have recently made changes to their positions in the business. Royce & Associates LP increased its holdings in PACS Group by 76.6% in the third quarter. Royce & Associates LP now owns 1,859,070 shares of the company’s stock valued at $25,525,000 after buying an additional 806,446 shares during the last quarter. Vanguard Group Inc. raised its stake in PACS Group by 14.4% during the fourth quarter. Vanguard Group Inc. now owns 4,506,227 shares of the company’s stock valued at $172,994,000 after buying an additional 566,502 shares in the last quarter. Crewe Advisors LLC lifted its holdings in PACS Group by 93.1% during the 4th quarter. Crewe Advisors LLC now owns 2,147,815 shares of the company’s stock worth $82,455,000 after buying an additional 1,035,747 shares during the last quarter. Fox Run Management L.L.C. lifted its holdings in PACS Group by 216.6% during the 3rd quarter. Fox Run Management L.L.C. now owns 36,502 shares of the company’s stock worth $501,000 after buying an additional 24,971 shares during the last quarter. Finally, Maven Securities LTD acquired a new position in shares of PACS Group in the 4th quarter worth approximately $960,000.
PACS Group Company Profile
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Featured Stories
- Five stocks we like better than PACS Group
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
